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Effets du chlorure d’aluminium sur certains éléments essentiels chez les rates gestantes et leurs
fœtus
Le but de notre étude est d’établir une relation de causalité entre l’injection intrapéritonéale d’AlCl3 et les
variations plasmatiques et tissulaires des teneurs en calcium, magnésium, cuivre, zinc, phosphore et fer chez les
rates gestantes et leurs fœtus. Les rates gestantes sont injectées du 9ème au 13ème jour de la gestation par
différentes doses d’AlCl3 (50, 100 et 200 mg/kg.j). Les éléments essentiels sont analysés dans le sang, les reins,
le foie et l’intestin des animaux par spectrophotométrie d’absorption atomique. Les résultats montrent, après
traitement par AlCl3, une augmentation des concentrations en calcium, fer et phosphore hépatique, aussi bien
qu’en fer et phosphore au niveau rénal, et une diminution des concentrations en magnésium rénal et intestinal,
en zinc hépatique, en cuivre hépatique et rénal, et en fer intestinal chez les rates gestantes et surtout pour les
fortes doses. On a aussi noté une augmentation des concentrations en calcium, en phosphore et en zinc dans le
plasma des rates gestantes et une diminution dans la concentration en magnésium dans le plasma des rates
gestantes et leurs fœtus pour les doses élevées d’AlCl3. Ces résultats prouvent que le passage de l’aluminium aux
fœtus suite au traitement des mères cause des perturbations dans le métabolisme des éléments essentiels.
Mots clés: Chlorure d’aluminium - Métabolisme minéral - Foie - Intestin - Rein - Rat
Effects of aluminium chloride on some essential elements in pregnant rats and their offspring
The aim of this study is to establish a relationship between intraperitoneal AlCl3 injection and variations of
plasma and tissue calcium, magnesium, copper, zinc, phosphorus, and iron concentrations in pregnant rats and
their offspring. The pregnant rats were injected on gestation days 9-13 with different doses of AlCl3 (50, 100, and
200 mg/kg.day). The essential elements were analyzed in blood, kidney, liver and intestine of the animals by
atomic absorption spectrophotometry, before and after AlCl3 injection. The results showed after AlCl3 treatment
an increase in hepatic calcium, iron and phosphorus concentrations, as well as in iron and phosphorus in the
kidney ; a decrease in renal and intestinal magnesium concentrations. Hepatic zinc, hepatic and renal copper and
intestinal iron concentrations of pregnant rats were also decreased. Moreover, we noted an increase in plasma
calcium, phosphorus and zinc concentrations with highest doses of AlCl3, and a decrease in magnesium
concentration in both pregnant rats and their offspring. These results provide evidence for the passage of
aluminium to the fetuses following maternal administration causing some disorders in the metabolism of
essential elements.
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INTRODUCTION
Aluminium is an abundant element in the earth’s
crust and is widely dispersed throughout the
environment. Nowadays, aluminum salts are
included in cosmetics, food processing and storage
and also used in various nonprescription drugs.
However, aluminum toxicity was initially
recognized as a neurological and/or skeletal
disease (Alfrey, 1986). On the other hand,
aluminium sulfate is extensively added as a
coagulant agent during the drinking water-
purification process in order to flocculate the
organic matter and so clarify the water (Domingo,
1993; Greger, 1993). The knowledge of aluminium
toxicity has markedly improved in recent years,
information concerning the reproductive toxicity
of this element is still very limited. A number of
investigations have suggested that pregnancy
could be a time of enhanced susceptibility to
aluminium toxicity (Golub & Domingo, 1996); and
a competition for transport with essential trace
elements is one of the possible mechanisms that
explains aluminium toxicity (Chmielnicka &
Nasiadek, 1991). It seems particularly relevant
during periods of rapid growth in late gestation
and early infancy when heavy demands are made
on trace element metabolism (Golub & Domingo,
1996). However, an important issue that has not
been addressed yet is the possible mobilization of
maternal aluminium stores in bone and other
tissues and a transfer to the fetus along with
calcium and other essential elements (Golub &
Domingo, 1996). A phenomenon that was already
demonstrated for lead (Silbergeld, 1991).
It was previously shown that AlCl3 affects
significantly hematocrit and hepatic, kidney and
intestinal proteins during rat pregnancy
especially for the highest AlCl3 dose used (200 mg/
kg.day) (Mestaghanmi et al., 2001).
However, there is relatively little information
about the effect of intraperitoneal injection of
aluminium chloride to the pregnant rats and their
fetuses on related mineral status, and also the
possible interactions of aluminum with essential
elements.
The aim of our study is to elucidate some effects of
intraperitoneal AlCl3 treatment of pregnant rats
on their offspring especially in terms of calcium,
magnesium, phosphorus, zinc, copper, iron
concentrations in plasma and different tissues of
the rats exposed to AlCl3 on gestation days 9-13.
MATERIALS AND METHODS
The experiments were performed on white female
Wistar rats of 230-260 g body weight. Female rats
were mated with male (3:1) overnight and
examined the following morning for copulatory
plugs. Day 1 was defined as the day when the
vaginal plug was found. The animals were
maintained on commercial pelleted chow, and tap
water ad libitum  in a room equipped with
automatic light cycles (12 h light/dark),
maintained at 22 ± 2°C with relative humidity of
40-60 %. The diet (N° GPF 81, from INAAM,
Casablanca, Morocco) contained average amounts
of: 160 g of protein, 20 g of fat, 70 g of mineral
supplements, 9 g of calcium, 3.5 g of phosphorus
per kilogram of diet. It also contained vitamin A,
D3 and E at relatively 10000, 1500, and 10 UI
respectively. Aluminum concentration in water
was 0.013 mg/l.
The animals were divided into two groups. The
first group was subdivided in three sub groups
(each subgroup contained 6 rats) which received
intra peritoneal injections of 50, 100 and 200 mg of
AlCl3/kg each day from the 9
 th to the 13 th of the
pregnancy days. Aluminium chloride (AlCl3) was
administered in physiological saline solutions at
doses 50, 100 and 200 mg/kg.day. The choice of
these doses was based on previous studies
concerning the developmental toxicity of
aluminum in mice, rats and rabbits (Bennet et al.,
1975; Cranmer et al., 1986; Yokel et al., 1989;
Chmielnicka et al., 1996; Sanchez et al., 1997). The
AlCl3 used for intraperitoneal injection was taken
from 20 sterile solution of AlCl3 (pH 2.4). The
second control group also received intraperitoneal
injections, but with only sterile physiological
saline for all gestation days from 9 to 13.
On the 20 th gestation day, the animals were killed
by decapitation. Blood was collected rapidly in
heparinized polypropylene tube from pregnant
rats and fetuses. Blood samples from same litter
fetuses were pooled, cooled at 4°C, centrifuged at
3000 g for 10 min. Liver, kidney and intestine were
quickly removed from pregnant rats and fetuses,
rinsed with sterile physiological saline, then
mineralized according to Cossa and Bourguet
(1980) for calcium, magnesium, copper, zinc, iron
and phosphorus determinations. Each tissue was
dried under 100°C, until the weight did not change.
Then, 0.2 g of the organ powder was put in
polypropylene tube with 4 ml of nitric acid (Merk,
70). The tubes were plugged for 12 h at room
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temperature (22 ± 2°C) then heated at 90°C for 3 h.
After cooling, the volume was completed to 50 ml
with bidistilled water filtered and stored at 4°C.
The blanks were prepared simultaneously to
prevent contamination.
For serum mineral components determination, we
have used the methods described by Willis (1959,
1960) for magnesium and calcium, Sprague &
Slavin (1965) for copper and zinc, Olson & Hamlin
(1969) for iron. The mineral phosphorus was
determined using the Biotrol Kit (Merk). Copper
concentrations were determined using graphite
furnace atomic absorption spectrophotometer
(Perkin-Elmer, 3030, equipped with HGA 600
graphite furnace and AS-60 automatic runner
samples). Other elements were determined by
flameless atomic absorption spectrophotometer
(GBC, Scientific Equipment, Victoria, Australia).
Statistical evaluations
Results (of the quantitative continuous variables)
were compared by analysis of variance (ANOVA-
MANOVA). Newman Keuls and Duncan’s
multiple-range tests were also used to evaluate
statistical significance among groups. A
probability value of p 0.05 was considered as
significant.
RESULTS
In the present study, increases of calcium,
phosphorus and zinc concentrations in plasma
were noted (p0.05) for AlCl3 injection at a dose of
200 mg/kg.day in pregnant rats (Table 1). The
magnesium and iron concentrations decrease
significantly in the plasma of pregnant rats and
their offspring at the highest AlCl3 dose used,
decrease in trends (n.s.) the plasma copper content
were also noted for both AlCl3-treated pregnant
rats and their offspring.
Tissue mineral concentrations of calcium, iron,
magnesium are summarized in table 2. There were
increases in calcium and iron concentrations in
pregnant rats treated by AlCl3 at the highest dose.
A decrease of magnesium was observed in kidney
and intestine of pregnant rats treated with AlCl3,
and to a lesser extent also in the offspring.
The concentrations of phosphorus, copper and zinc
in liver kidney and intestine are presented in table
3. The AlCl3 treatment of pregnant rats induced an
increase in the hepatic and renal phosphorus
Table 1. Ca, P, Fe, Mg, Zn, and Cu mineral
concentrations in plasma (µ/ml) of
pregnant rats and their offspring
exposed to AlCl3 at a dose of 50, 100 and
200 mg/kg.day from day 9 to day 13 of
gestation
Min. AlCl3 dose 50 100 200
mg/kg.day
Ca Mothers
Controls 1,801±0,223 1,837±0,215 1,900±1,128
Treated 1,713±0,321 1,800±0,091 2,299±0,199*
Fetuses
Controls 1,805±1,550 1,830±0,140 1,795±0,091
Treated 1,780±0,119 1,607±0,129 1,910±0,091
P Mothers
Controls 106,560±4,815 103,452±3,215 104,000±2,903
Treated 104,27±4,829 106,155±0,630 112,035±1,583 *
Fetuses
Controls 92,882±2,756 92,338±3,541 91,939±3,186
Treated 92,875±1,361 91,992±0,979 91,482±0,703
Fe Mothers
Controls 9,089±1,591 9,098±1,113 9,077±0,436
Treated 9,095±0,277 9,057±0,307 8,265±0,230*
Fetuses
Controls 10,410±1,072 10,390±0,770 10,477±0,566
Treated 10,247±1,224 9,938±0,851 9,700±0,806
Mg Mothers
Controls 2,881±0,134 2,951±0,102 2,862±0,161
Treated 2,900±0,129 2,740±0,141 2,527±0,168 *
Fetuses
Controls 3,075±0,125 3,108±0,126 3,045±0,149
Treated 3,122±0,116 2,930±0,123 2,727±0,068 *
Zn Mothers
Controls 1,164±0,065 1,189±0,791 1,133±0,898
Treated 1,147±0,240 1,559±0,099 1,776±0,304 *
Fetuses
Controls 1,496±0,120 1,419±0,098 1,398±0,083
Treated 1,753±0,113 1,720±0,265 1,865±0,084
Cu Mothers
Controls 0,885±0,166 0,914±0,205 0,885±0,218
Treated 0,881±0,171 0,855±0,096 0,765±0,088
Fetuses
Controls 0,632±0,009 0,625±0,026 0,614±0,058
Treated 0,642± 0,009 0,609± 0,067 0,551±0,051
Min. : Minerals ; *:  p  0.05
content but had no effects on their offspring. We
have also observed a decrease in zinc and copper
tissue concentrations in liver and kidney from
pregnant rats treated by AlCl3 (p < 0,05), with no
changes in fetuses. We noted a decrease in hepatic
and renal copper (p < 0,05) concentrations in AlCl3-
treated pregnant rats but there was no variation in
their offspring for any tissue.
       Actes Inst. Agron. Vet. (Maroc) 2002, Vol. 22 (4)                     Mestaghanmi et al.: Effects of AlCl
3
 injection on pregnant rats230
Table 2. Concentrations of Ca, Mg, Fe (µg/g dry
weight of tissue) in liver, kidney and
intestine from pregnant rats and their
offspring exposed to AlCl3 at a dose of  50,
100, and 200 mg/kg.day from day 9 to day
13 of  gestation
Min. Tissues Liver Kidney Intestine
Ca Mothers
Controls 50 218,13±7,79 358,80±1,62 403,10±2,92
Treated 50 219,56±7,46 358,67±2,21 402,86±3,95
Controls 100 222,39±5,21 358,89±1,86 402,63±2,76
Treated 100 217,82±2,04 356,52± 4,03 403,93±4,19
Controls 200 220,50±7,69 357,77± 0,98 402,81±3,44
Ca Treated 200 230,77±0,14 * 350,62±0,542 495,99±1,242 *
Fetuses
Controls 50 267,92±4,39 394,97± 6,67 408,33± 2,65
Treated 50 266,71± 4,75 393,25± 1,70 408,48± 2,93
Controls 100 269,78±1,56 393,68± 3,64 407,36± 1,48
Treated 100 265,36±4,60 394,62± 3,16 407,90± 4,04
Controls 200 269,25±2,31 392,75± 4,04 406,90± 1,85
Treated 200 272,41±0,73 398,37± 1,29 410,20± 1,25
Mg Mothers
Controls 50 331,26±5,03 533,20± 3,62 601,86± 3,06
Treated 50 331,44±6,92 535,94± 2,78 602,77± 3,65
Controls 100 331,04±1,12 534,39± 3,92 598,69± 6,91
Treated 100 332,31±3,00 534,15± 3,27 596,75± 1,17 *
Controls 200 330,98±7,96 538,01±1,59 602,65±3,22
Treated 200 336,41±3,18 528,06±1,26 * 583,58±2,11 **
Fetuses
Controls 50 361,04±4,97 542,92±1,61 585,56±4,20
Treated 50 362,73±5,92 542,90±1,76 586,57±3,37
Controls 100 361,55±0,93 543,25±1,27 588,22±1,1,69
Treated 100 361,20±2,49 541,88±1,00 582,11±1,33
Controls 200 362,35±7,76 542,83±2,72 587,87±1,88
Treated 200 361,12±1,79 538,40±1,67 576,69±2,40
Fe Mothers
Controls 50 399,22±9,41 131,30±1, 42 117,55±1,75
Treated 50 396,41±3,96 131,20±1,76 116,12±3,49
Controls 100 402,01±6,04 129,75±2,68 116,61±1,77
Treated 100 392,00±9,84 136,85±2,61 117,49±4,42
Controls 200 399,90±3,68 129,85± 2,61 115,35±2,11
Treated 200 414,94±11,24* 142,54±0,46* 125,07±2,55 *
Fetuses
Controls 50 420,05±1,26 117,25±1,37 122,65±3,07
Treated 50 420,35±1,28 117,38±2,17 120,05±1,26
Controls 100 419,29±2,19 116,63±1,62 121,10±1,18
Treated 100 416,77±3,48 115,16±1,11 119,25±1,50
Controls 200 420,27±3,14 118,36±1,64 121,84±2,51
Treated 200 414,40±1,56 114,27±1,67 119,15±1,24
Min. : Minerals ; *:  p  0.05  ; **:  p  0.005
Table 3. Mineral concentrations of  P (mg/g dry
weigh of tissue), Zn, and Cu (g/g dry
weigh of tissue) in liver, kidney and
intestine from pregnant rats and  their
offspring exposed to AlCl3 at a dose of 50,
100, and 200 mg/kg.day from day 9 to day
13 of gestation
Min. Tissues Liver Kidney Intestine
Cu Mothers
Controls 50 20,74± 1,24 27,97±0,80 17,99±0,44
Treated 50 20,55±0,81 27,68±0,56 17,70±0,42
Controls 100 21,53±0,93 28,84±0,57 18,08±0,31
Treated 100 18,99±0,36 19,80±0,46* 18,30±0,48
Controls 200 20,82±1,22 28,84±0,60 18,23±0,50
Treated 200 17,27±0,76 * 13,97±0,46 ** 18,45±0,84
Fetuses
Controls 50 19,00± 0,42 27,38±0,86 16,87±0,26
Treated 50 18,92±0,32 27,27±0,89 16,78±0,45
Controls 100 18,84± 0,61 27,40±0,59 16,80±0,40
Treated 100 18,60±0,33 26,58±0,88 17,00±0,18
Controls 200 18,97±0,41 27,09±0,57 16,95± 0,33
Treated 200 18,25±0,28 26,23±0,94 17,16±0,36
Zn Mothers
Controls 50 126,46± 3,21 87,80±1,41 76,25±0,81
Treated 50 124,50±2,94 86,58±1,07 76,60±1,42
Controls 100 126,00±3,81 87,16±1,26 75,95±1,28
Treated 100 126,40±4,49 87,72±0,55 78,02±1,25
Controls 200 126,77±2,53 87,47±1,41 76,51±0,83
Treated 200 119,31 0,74 * 83,84±0,95* 78,35±2,19
Fetuses
Controls 50 133,77± 1,37 88,22±1,17 78,35±0,94
Treated 50 134,10±2,653 87,94±0,61 78,18±0,94
Controls 100 133,55±1,71 87,58±0,75 78,52±0,53
Treated 100 133,47±0,81 87,17±1,18 78,81±0,37
Controls 200 134,115±1,945 87,39±1,67 78,57±0,78
Treated 200 132,86±0,68 87,30±1,65 79,50±0,71
P Mothers
Controls 50 17,99±0,45 13,90±0,56 10,93± 0,16
Treated 50 17,60±0,41 13,85±0,45 10,90±0,29
Controls 100 18,30±0,38 13,75±0,22 11,02±0,06
Treated 100 16,17±0,24 13,73±0,62 11,20±0,35
Controls 200 18,22±0,38 13,70±0,21 11,05±0,19
Treated 200 20,00±0,45 * 15,52±0,36* 11,13±0,75
Fetuses
Controls 50 18,32±0,23 15,34±0,31 10,41±0,07
Treated 50 18,49±0,47 15,21± 0,16 10,41±0,22
Controls 100 18,33±0,14 15,25±0,21 10,45±0,14
Treated 100 17,89±0,58 15,01±0,43 10,47±0,09
Controls 200 18,24±0,38 15,20±0,29 10,46±0,15
Treated 200 18,81±0,38 14,52±0,13 10,41±0,20
Min. : Minerals ; * :  p  0.05 ; ** :  p  0.005
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metallothionein synthesis. Thionein fixes copper
in intestinal cells which become inapt for plasma
transfer.
We have noted an alteration in calcium,
phosphorus and zinc concentrations of pregnant
rats without any perturbations for their offspring
mineral components. This suggests that the
placenta plays an important role to palliate the
toxic effects of AlCl3 and the young age of the
animal is also a good criteria for reduction of toxic
effects of AlCl3 (Sanchez et al., 1997).
We have observed a decrease in serum iron
concentration. This decrease can be explained by
the fact that aluminium can be carried by
transferrin (the protein that transport Fe) or
albumin (Van Ginkel et al. , 1990) in tissue.
Chmielnicka et al., (1994) have studied effect of
AlCl3 (100 mg/kg for 21 days in rats Wistar), they
caused normocytic anemia. They have also
observed (Chmielnicka et al., 1996; Mahieu et al.,
2000) a significant decrease in serum iron
concentration after each week of exposure of 4 mg/
kg.day. Chmielnicka & Nasiadek (1991) have also
observed a decrease in blood iron accompanied by
an increase in plasmatic calcium. Han et al., (2000)
have observed that aluminium exposure alters
tissue iron and ferritin, the protein that stores Fe,
concentrations in chick. Vittori et al. (2002) have
observed that anemia is associated with
aluminium, erythrocyte morphological changes
were induced by aluminium during in vitro ageing.
The cells lost their typical biconcave shape.
Aluminium was found within the cells and
attached to the membrane. They suggest that
aluminum may disturb human erythropoiesis
through combined effects on mature erythrocytes
and cellular metabolism in late erythroid
progenitors.
We have also noted a decrease in plasmatic
magnesium in AlCl3-treated pregnant rats and
their offspring. This decrease may be related to
calcium and phosphorus concentration variations
or to an hyperparathyroidism as observed by
Alfrey (1985) and Felsenfel et al. (1993). This can
be explained by a change in the relationship
between calcium and phosphorus and between
calcium and the parathyroids secretion. The
hyperparathyroidism protects the bone against
demineralization when there is an aluminium
toxic effect. In other respects the decrease in
plasmatic magnesium can be related to a
nephrotoxicity caused by aluminum causing a
DISCUSSION
In the present study, we observed that AlCl3
induced some modifications in the plasmatic and
tissue mineral element concentrations of pregnant
rats and their offspring at the highest dose used.
These variations were mainly characterized by
decreases in renal and intestinal magnesium
concentrations, hepatic and renal copper contents,
increases in renal, hepatic and intestinal iron and
calcium, renal and hepatic phosphorus
concentrations and decreases in renal and hepatic
zinc concentrations.
First of all, in pregnant Al-induced rats, the
plasmatic mineral elements show an
hypercalcaemia. This may be explained by a loss of
bone mineral elements because the calcium plays
an important role in homeostasis (Jackson et
al. ,1985). Thus, AlCl 3 treatment alters bone
mineralization and activates calcium transit
toward blood. A decrease in renal calcium
excretion may also explain the hypercalcaemia.
This nephrotoxicity has been observed in rats by
Liu & Nordberg (1995) after intraperitoneal
injections of AlCl3. Muller et al. (1993) have
observed a significant rise of calcium in serum and
spleen of adult rats, as well as in newborns whose
mother received oral aluminium lactate. A slight
hypercalcaemia (but n.s.) was observed in fetuses
whose mothers were treated by AlCl3.
This agrees with the results of Muller et al. (1993).
They have demonstrated in rats that aluminum
lactate treatment induces, an increase in plasma
calcium accompanied by a decrease in magnesium
concentration because magnesium serves as a
substitute for calcium in bone mineralization
when there is an alteration of calcium bone
fixation. The hyperphosphatemia observed in
pregnant rats treated with AlCl3 (but not in their
offspring) likely occurs when an increase in
phospholipids happens because all HDL fractions
increased (Mahieu & Calvo, 1998).
In pregnant rats treated with AlCl 3 the
hyperzincemia and the lower decrease (n.s.) in
copper content (especially with highest doses of
AlCl3) may be explained by the relationship
between copper and zinc which are competitive for
protein intestinal (metallothionein) site fixation.
Indeed, zinc inhibits the copper intestine
absorption (O’Neil Cutting et al., 1981). This
suggests that zinc is an antagonist to copper
absorption because it induces intestinal
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decrease in renal magnesium reabsorption. A
negative effect of aluminium on magnesium levels
in serum, bones and kidney was observed in sheep
after oral exposure. Lower magnesium
concentration in bones is probably not only a result
of its lower concentration in blood, but also points
to disturbances of magnesium metabolism (Allen,
1985, Muller et al. , 1993). It was also noted that
magnesium level is lower in carcasses of newborn
offspring of rat fed aluminium compounds, as
these rats also showed lower magnesium level in
blood (Muller et al., 1993).
About tissue mineral components, we have
observed an increase in hepatic and intestinal
calcium concentrations in pregnant rats treated by
200 mg of AlCl3/kg.day as well as in their offspring.
These data are in good agreement with those of
Chmielnicka & Nasiadek (1991) and Dlugaszek et
al. (2000) who have observed a perturbation in
hepatic calcium metabolism. They have also noted
an increase in urinary calcium excretion. After
aluminium treatment, there is a calcium bone loss
which causes an hypercalcaemia and an increase
in hepatic calcium concentration. This should be a
protective effect for homeostasis. In fetuses,
aluminum passes through the placenta from
pregnant rats and modifies the calcium content.
Phosphorus is an important element for the
skeleton. Its absorption occurs in the different
parts of the intestinal tract. In duodenum, the
phosphorus is widely absorbed in presence of
vitamin D (Moya, 1987). The plasmatic
phosphorus level is controlled by parathyroid
hormone. In fact, this hormone favors the
absorption of phosphorus in the intestine when
calcium is also absorbed. This leads, to an increase
in the quantity of phosphorus and calcium which
are elimined in feces (Mahieu & Calvo, 1998).
In AlCl3-treated pregnant rats, we have only
observed a decrease in hepatic and kidney zinc
concentration which probably causes toxic effects
in liver. Zhang et al. (1998) have reported that
gavage or “underskin“ injection of aluminum
induces metallothionein in the rat. This induction
reflects the response to stress caused by
aluminum. Thus, the detoxication effect is
uncertain and the metallothionein induction in
liver sites may influence zinc metabolism. The
decrease observed in renal and hepatic copper
concentrations may be explained by the
interaction between zinc and copper which are
competitors for the protein sites fixation. Zinc
inhibits copper absorption (O’Neill Cutting et al.,
1981), by induction of intestinal methallothionein
synthesis that retens copper. Yang et al. (1998)
showed that aluminium could alter copper
homeostasis in brain of mice after prolonged
administration of AlCl3.
When pregnant rats are treated with AlCl3, there
is a decrease in renal and intestinal magnesium
concentrations, but not in liver magnesium
content. This can be attributed to a nephrotoxicity,
thus magnesium is not reabsorbed by kidney (Liu
& Nordberg, 1991).
The increase in intestinal, renal and hepatic iron
concentrations in AlCl3-treated pregnant rats can
be explained by a decrease in intestinal proteins
concentration after an aluminum treatment
(Mestaghanmi et al. , 2001) which causes a
perturbation in the absorption of amino-acids
(Dlugaszek et al., 2000). Morgan & Redgrave
(1998) have shown a relationship between
intestinal absorption, transit in plasma and
induction of lipid peroxidation with cell damages
related to aluminum treatment. The increase in
tissue iron content may be attributed to the
promotion of transferrin receptor synthesis while
blocking ferritin synthesis (Ward et al., 2001). In
cells, transferrin receptors are able to bind
transferrin, which may carry iron Fe3+  or
aluminium, with similar affinity
Perez et al. (2001) and Han et al. (2000) have
suggested that aluminum inhibits iron absorption
and disrups the regulation of tissue ferritin levels.
AlCl3 injected into pregnant rats causes some
metabolic perturbations in mothers and fetuses
especially in regard to plasmatic calcium,
phosphorus and magnesium concentrations and in
their tissue mineral component.
This disturbances of essential element induces
disturbances on skeleton, neurological functions
and erythropoietic system in human. To prevent
the potential disturbances caused by aluminium
ingestion during pregnancy we must avoid the
consumption of Al-containing antacids, as well as
other Al-containing products, which can be easily
replaced by other compounds.
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